Apellis Pharmaceuticals Inc (APLS) Company Profile & Statistics

Apellis Pharmaceuticals Inc
APLS
(Nasdaq - US)
Closed
27.74
+0.25 (+0.91%)
in:usd•As of: Nov 21, 2024 15:59 UTC -5
Open
26.98
High
28.13
Low
26.64

About Apellis Pharmaceuticals Inc

CEO

Cedric Francois

Headquarters

100 fifth avenue

waltham, ma 02451, united states

Auditor

Deloitte & Touche LLP

Employees

706

Share Holders

Website

www.apellis.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Apellis Pharmaceuticals, Inc. is a clinical-stage biotech focused on the development of novel therapeutics, which work through the inhibition of the complement system, specially targeting the C3 protein of the complement system to treat autoimmune and inflammatory diseases.

Apellis Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization ²	3.45B
Enterprise Value	3.50B
Enterprise Value/EBITDA (ttm)	-17.09
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	15.21
Price to Sales (ttm)	5.04
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	86.51%
Operating Margin (ttm)	-34.70%
Profit Margin (ttm)	-36.78%
Return on Equity (ttm)	-103.11%
Return on Invested Capital (ttm)	-62.82%
Return on Assets (ttm)	-28.96%

Income Statement

Revenue (ttm)	715.22M
Revenue Per Share (ttm)	5.75
Gross Profit (ttm)	618.44M
EBITDA (ttm)³	-205.10M
Net Income Avi to Common (ttm)	-250.10M
Diluted EPS (ttm)	-2.03

Share Statistics

Beta (5Y Monthly)	0.87
52-Week Change	-43.96%
S&P500 52-Week Change	30.55%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	124.39M
Dividend Yield	0.00%
Float ⁴	115.93M
% Held by Insiders	6.80%
% Held by Institutions	96.29%

Balance Sheet

Total Cash (mrq)	398.24M
Total Cash Per Share (mrq)	3.20
Total Debt (mrq)	452.25M
Total Debt/Equity (mrq)	190.72%
Current Ratio (mrq)	4.36%
Quick Ratio (mrq)	3.73%
Book Value Per Share (mrq)	1.94

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.86
Free Cash Flow (ytd)	-107.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Apellis Pharmaceuticals Inc

Trade With A Regulated Broker